GlassScriptPhysician profile
Olcay Aksoy
NPI 1881748630
$57,636.22
in general payments reported to CMS, 2019-2025
22 companies · $6,274 in 2025
The $6,274 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,953 · 2020: $1,306 · 2021: $2,897 · 2022: $8,503 · 2023: $31K · 2024: $6,002 · 2025: $6,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $31K · Food and Beverage: $9,084 · Consulting Fee: $3,125 · Grant: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $30,643.46 |
| Food and Beverage | $9,083.65 |
| Consulting Fee | $3,125.00 |
| Grant | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $29,729.44 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Siemens Medical Solutions USA, INC. | $10,646.16 | 2023 | Naeotom Alpha, Artis Icono Floor, Syngo Dynamics |
| Ge Healthcare | $7,266.94 | 2023 | |
| Medtronic, INC. | $3,298.61 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Affera Mapping System |
| Abbott Laboratories | $2,987.98 | 2019-2025 | Triclip, Coroflow, Dragonfly Opstar |
| Boston Scientific Corporation | $709.36 | 2019-2025 | Emerge Push, Avvigo Guidance System, Sentinel |
| Shockwave Medical, INC | $683.80 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $624.13 | 2019-2025 | |
| Philips North America LLC | $405.74 | 2021-2022 | |
| Penumbra, INC. | $383.54 | 2022 | |
| Heartflow, INC. | $282.54 | 2025 | |
| Medtronic Vascular, INC. | $196.59 | 2019 | |
| Cardiva Medical, INC. | $164.64 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Janssen Pharmaceuticals, INC | $123.03 | 2024 | Xarelto |
| Cardiac Dimensions, INC. | $31.75 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.30 | 2020 | |
| Viiv Healthcare Company | $30.28 | 2019 | |
| Lilly USA, LLC | $15.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.32 | 2021 | |
| Chiesi USA, INC. | $12.86 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olcay Aksoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.